Informatie:
Fout:
ID
34266
Beschrijving
The Norwegian Pancreas Transplantation (PTx) Study; ODM derived from: https://clinicaltrials.gov/show/NCT01957696
Link
https://clinicaltrials.gov/show/NCT01957696
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes Mellitus NCT01957696
Eligibility Diabetes Mellitus NCT01957696
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus NCT01957696
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
age ≥18 years
boolean
ID.2
Item
patients who receive a primary or secondary pancreas transplant, with or without a simultaneous kidney transplant (spk).
boolean
ID.3
Item
women who are of childbearing potential must have a negative serum pregnancy test at baseline.
boolean
ID.4
Item
operability has to be ascertained by preoperative examination, performed by nephrologist, transplant surgeon and anaesthesiologist.
boolean
ID.5
Item
signed and dated informed consent form.
boolean
ID.6
Item
evidence of systemic infection
boolean
ID.7
Item
presence of unstable cardiovascular disease.
boolean
ID.8
Item
malignancy < 5 years prior to entry into the trial (with the exception of adequately treated basal cell or squamous cell carcinomas of the skin).
boolean
ID.9
Item
panel-reactive antibodies (pra) > 20% or the presence of donor-specific antigens (dsa).
boolean
ID.10
Item
any positive test for hbv, hbc or hiv.
boolean